Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07831772) titled 'REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma' on Sept. 9.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Minnesota

Condition: Glioblastoma Newly Diagnosed Glioblastoma Brain Tumor

Intervention: Radiation: Maintenance Radiotherapy

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: August 24, 2026

Target Sample Size: 4

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07831772

Pu...